Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
Cerina LeeJessica M RoundScott KlarenbachJohn G HanlonElaine HyshkaJason R B DyckDean T EurichPublished in: Harm reduction journal (2021)
In both AB and ON, the majority of reasons for medical cannabis authorization are not substantiated by clinical evidence to fully support its efficacy for long-term use. Ongoing epidemiological studies on medical cannabis on these treatments are warranted to fully outline its treatment benefits or risks.